Publicacions en col·laboració amb investigadors/es de Hospital Duran i Reynals (3)

2018

  1. Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis

    The Lancet Respiratory Medicine, Vol. 6, Núm. 10, pp. 771-781

2009

  1. Predictors of long-term survival in patients with lung cancer included in the Randomized Spanish Lung Cancer Group 0008 Phase II trial using concomitant chemoradiation with docetaxel and carboplatin plus induction or consolidation chemotherapy

    Clinical Lung Cancer, Vol. 10, Núm. 3, pp. 180-186

2007

  1. XPD 312 single nucleotide polymorphism (SNP) predicts survival in stage IIIA-B non-sinall-cell lung cancer (NSCLC) patients (pts) < 59 years (y) treated with chemotherapy followed by surgery

    EJC SUPPLEMENTS